Australian Prescriber Podcast
Australian Prescriber
Show overview
Australian Prescriber Podcast has been publishing since 2017, and across the 9 years since has built a catalogue of 224 episodes. That works out to roughly 65 hours of audio in total. Releases follow a fortnightly cadence.
Episodes typically run ten to twenty minutes — most land between 14 min and 20 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.
The show is actively publishing — the most recent episode landed 4 days ago, with 20 episodes already out so far this year. Published by Australian Prescriber.
From the publisher
The Australian Prescriber Podcast provides a regular dive into some of the many great articles that Australian Prescriber publishes every two months. In each episode, our host will chat with one of the authors from a recent issue of Australian Prescriber.
Latest Episodes
View all 224 episodesE224 - High prevalence of syphilis in Australia: test, treat and trace
E223 - Rheumatic fever and rheumatic heart disease: updates for clinical practice
E222 - Acne vulgaris: a clinical update
E221 - Antibiotic prophylaxis for dental procedures an update
E220 - The role of oral antiviral therapies for acute COVID-19
E219 - Sodium valproate: balancing benefits and risks especially in people of childbearing potential
E218 - Diagnosis and management of irritable bowel syndrome
E217 - Emergency contraception: an overview
E216 - Cardiovascular-kidney-metabolic (CKM) syndrome
E215 - Vitamin B12 deficiency: testing and treatment
E214 - Therapeutic Guidelines Kidney and Urinary
E213 - Metabolic dysfunction–associated fatty liver disease an update
E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals
Ep 211E211 - Preventing infections in immunosuppressed patients
Dhineli Perera speaks to infectious diseases physicians Aadith Ashok and Bradley Gardiner about their paper on preventing infections in immunosuppressed patients. They explain how to individualise risk assessments and screening investigations, and discuss antimicrobial prophylaxis and helpful safe living advice for patients. Read the full article in Australian Prescriber.
Ep 210E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective?
David Liew talks to rheumatologist Jessica Pisaniello about her paper on Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis. They discuss the limited benefits and the risks of using of hyaluronic acid in joints, what current guidelines recommend, and what the evidence says. Jessica also advises on how to approach conversations with patients who ask prescribers about using hyaluronic acid. Read the full article in Australian Prescriber.
Ep 209E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
Laura Beaton chats with David Brieger, head of cardiology at Concord Hospital, Sydney, about the 2025 Australian acute coronary syndromes [ACS] clinical guideline. David explains the importance of secondary prevention for ACS, including new approaches to tailoring the duration of dual antiplatelet therapies, new lipid targets, and the limited role of beta blockers and colchicine. Read the full article in Australian Prescriber.
Ep 208E208 - Pharmacological management of attention deficit hyperactivity disorder in adults
In a follow-up to our episode on attention deficit hyperactivity disorder (ADHD) in children and adolescents, Justin Coleman talks to psychiatrist Shuichi Suetani about the pharmacological management of ADHD in adults. They discuss the different considerations for managing adults compared with children, as well as important adverse effects and monitoring of ADHD medications. Shuichi also outlines other factors to consider when assessing treatment response. Read the full article in Australian Prescriber.
Ep 207E207 - Injectable drugs for weight management
Jo Cheah talks to Terri-Lynne South, Medical Director at Lifestyle Metabolic in Brisbane, about her paper on injectable drugs for weight management. Terri-Lynne outlines the available GLP-1 drugs and how they work in managing weight. The conversation also covers important considerations for prescribers, including off-label use, potential adverse effects and the need for behavioural and lifestyle modifications. Read the full article by Terri-Lynne and her co-author Natasha Yates in Australian Prescriber.
Ep 206E206 - Testing for human immunodeficiency virus
Justin Coleman chats with sexual health physician Louise Owen about her paper on HIV testing. The conversation covers who and when to test, including higher risk populations and indicator conditions, and the types of HIV tests available, such as rapid point-of-care testing. Read the full article in Australian Prescriber.
Ep 205E205 - Top 10 drugs 2024-25
AP Podcast hosts David Liew and Dhineli Perera talk about Australia's top 10 drugs over the last year. They discuss the top drugs dispensed under the PBS, based on prescription count and cost to the government. They touch on changes to the use of certain drug classes such as oral anticoagulation, and the impact of the COVID pandemic on antiviral drug use. Read the full article for 2024-25 in Australian Prescriber.